Clinical Trial Update: Intra-arterial Bone-marrow Mononuclear Cells Infusion for Acute Ischemic Stroke [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating intra-arterial bone-marrow mononuclear cell infusion for ischemic stroke has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• bone-marrow mononuclear cell infusion (bone-marrow mononuclear cells)

Snippet

Sponsor: Andalusian Initiative for Advanced Therapies | Conditions: Ischemic Stroke | Phase 2 | Status: COMPLETED